Non-viral gene-activated matrices: next generation constructs for bone repair

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Gene Therapy

Background:

• Viral vectors raise safety concerns in gene therapy.
• Transient gene expression is crucial for tissue engineering applications.
• Mesenchymal stem cells (MSCs) are vital for bone regeneration but hard to transfect.

Purpose of the Study:

• To develop non-viral gene-activated matrices (GAMs) for enhanced therapeutics in regenerative medicine.
• To optimize non-viral vectors for efficient transfection of mesenchymal stem cells (MSCs).
• To investigate the efficacy of different collagen-based scaffolds in supporting transgene expression.

Main Methods:

• Developed gene-activated matrices (GAMs) using non-viral gene therapy (GT) and collagen-based scaffolds.
• Optimized polyethyleneimine (PEI) for high transfection efficiency in MSCs.
• Incorporated ephrinB2 gene into GAMs for bone repair applications.

Main Results:

• Achieved high transfection efficiencies in MSCs using optimized PEI.
• Detected transgene expression up to 21 days with collagen-nanohydroxyapatite (collagen-nHa) scaffolds.
• Developed PEI-based GAMs with a low plasmid DNA dose (2 µg).

Conclusions:

• Non-viral GAMs offer a promising alternative to viral vectors for regenerative medicine.
• Collagen-nHa scaffolds provide prolonged transgene expression for tissue engineering.
• Novel therapeutic GAMs incorporating ephrinB2 show potential for bone repair.